This white paper is based on the professional research and comprehensive analysis of Frost & Sullivan. Driven by policy dividends, accelerated compliance, and consumption upgrading, the Chinese medical aesthetics industry is entering a new phase of 'strong regulation and quality improvement'. Institutions with medical qualifications, R&D capabilities, and chain operation experience will become the core force in industry integration, driving the industry towards standardized, normalized, and transparent development.
Meanwhile, non-surgical medical aesthetics services have been growing rapidly mainly due to their naturalness, safety, and quick recovery, which align with contemporary consumer preferences; technological progress has also promoted the widespread application of injection fillings and photoelectric projects.
Frost & Sullivan has found through research that there are significant differences in the cognitive and decision-making behaviors of different types of consumers towards anti-aging services. In addition, although there is a consensus within the medical community on segment-specific anti-aging approaches, consumers generally lack awareness of the correct methods and there is a clear cognitive disalignment. In the future, the medical aesthetics industry should promote the collaborative construction of 'medical consensus - consumer awareness - business implementation', to drive anti-aging services towards specialization and systematization.
